Literature DB >> 19507066

Secondary RNA structure and its role in RNA interference to silence the respiratory syncytial virus fusion protein gene.

Komal Vig1, Nuruddeen Lewis, Eddie G Moore, Shreekumar Pillai, Vida A Dennis, Shree R Singh.   

Abstract

RNA interference (RNAi) is a post-transcriptional, gene silencing mechanism which uses small interfering RNA molecules (siRNA) for gene silencing. Respiratory Syncytial Virus (RSV) is an important respiratory pathogen of medical significance that causes high mortality in infants. The fusion (F) protein of RSV is a good target for therapeutic purposes as it is primarily responsible for penetration of the virus into host cells and subsequent syncytium formation during infection. In the present study, four siRNAs were designed and used individually as well as a mixture, to silence the RSV F gene. The relationship between siRNA design, target RNA structure, and their thermodynamics was also investigated. Silencing of F gene was observed using indirect immunofluorescence, western blot, reverse transcription PCR, and progeny viral titers. Our results show F gene silencing by all the four siRNAs individually and collectively. RT-PCR analysis revealed a decrease in mRNA level which corresponded to decreased F protein expression. siRNAs also inhibited RSV progeny as shown by viral titer estimation on infected HEp-2 cells. The present study demonstrates the silencing of the F gene using siRNA. Thermodynamic characteristics of the target RSV mRNA and siRNA seem to play an important role in siRNA gene silencing efficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507066     DOI: 10.1007/s12033-009-9190-8

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  46 in total

1.  Target accessibility dictates the potency of human RISC.

Authors:  Kirk M Brown; Chia-Ying Chu; Tariq M Rana
Journal:  Nat Struct Mol Biol       Date:  2005-04-24       Impact factor: 15.369

2.  siRecords: an extensive database of mammalian siRNAs with efficacy ratings.

Authors:  Yongliang Ren; Wuming Gong; Qiqi Xu; Xin Zheng; Dong Lin; Yejun Wang; Tongbin Li
Journal:  Bioinformatics       Date:  2006-01-28       Impact factor: 6.937

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 4.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

6.  Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.

Authors:  Ruo-Su Ying; Cai Zhu; Xue-Gong Fan; Ning Li; Xue-Fei Tian; Hong-Bo Liu; Bao-Xin Zhang
Journal:  Antiviral Res       Date:  2006-06-28       Impact factor: 5.970

7.  RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.

Authors:  Wenliang Zhang; Ralph A Tripp
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

8.  Analysis of gene function in somatic mammalian cells using small interfering RNAs.

Authors:  Sayda M Elbashir; Jens Harborth; Klaus Weber; Thomas Tuschl
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

9.  Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design.

Authors:  Zhi John Lu; David H Mathews
Journal:  Nucleic Acids Res       Date:  2008-05-15       Impact factor: 16.971

10.  Inhibition of Henipavirus infection by RNA interference.

Authors:  Bruce A Mungall; Nick C T Schopman; Luke S Lambeth; Tim J Doran
Journal:  Antiviral Res       Date:  2008-08-05       Impact factor: 5.970

View more
  6 in total

1.  Atomic force microscopic investigation of respiratory syncytial virus infection in HEp-2 cells.

Authors:  P M Tiwari; E Eroglu; S Boyoglu-Barnum; Q He; G A Willing; K Vig; V A Dennis; S R Singh
Journal:  J Microsc       Date:  2013-11-19       Impact factor: 1.758

2.  Inhibition of Respiratory Syncytial Virus Replication by Simultaneous Targeting of mRNA and Genomic RNA Using Dual-Targeting siRNAs.

Authors:  Somayeh Shatizadeh Malekshahi; Vahid Salimi; Ehsan Arefian; Ghazal Fatemi-Nasab; Sarvin Adjaminejad-Fard; Jila Yavarian; Talat Mokhtari-Azad
Journal:  Mol Biotechnol       Date:  2016-11       Impact factor: 2.695

Review 3.  Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.

Authors:  Janyra A Espinoza; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

4.  Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response.

Authors:  Swapnil S Bawage; Pooja M Tiwari; Ankur Singh; Saurabh Dixit; Shreekumar R Pillai; Vida A Dennis; Shree R Singh
Journal:  Nanomedicine       Date:  2016-07-02       Impact factor: 5.307

Review 5.  Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.

Authors:  Swapnil Subhash Bawage; Pooja Munnilal Tiwari; Shreekumar Pillai; Vida Dennis; Shree Ram Singh
Journal:  Adv Virol       Date:  2013-12-09

6.  siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication.

Authors:  María Martín-Vicente; Salvador Resino; Isidoro Martínez
Journal:  Biomolecules       Date:  2019-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.